ATE193451T1
Verotoxin pharmaceutical compositions and medical treatments therewith
Abstract
Pharmaceutical compositions comprising known verotoxins, particularly, verotoxin 1, have been found to be useful in the treatment of mammalian neoplasia, particularly, ovarian cancer and skin cancer. Surprisingly, although verotoxin 1 has previously been shown to have anti-neoplastic activity in vitro, non-lethal doses of verotoxin 1 have been shown to be therapeutically anti-neoplastic in vivo.
Term
Term ended
Projected expiry passed 20 February 2015, 11.6 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
53 members in 10 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 2116179 | Canada | A | |
| 9500085 | Canada | W |
Members53
| Document | Office | Kind | |
|---|---|---|---|
| CA2116179A1 | Canada | A1 | |
| WO9522349A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1703195A | Australia | A | |
| EP0746337A1 | European Patent Office (EPO) | A1 | |
| JPH10500103A | Japan | A | |
| AU701100B2 | Australia | B2 | |
| US5968894A | United States of America | A | |
| NZ331165A | New Zealand | A | |
| EP0746337B1 | European Patent Office (EPO) | B1 | |
| AT193451T | Austria | T | |
| ATE193451T1This record | Austria | T1 | |
| DE69517302D1 | Germany | D1 | |
| ES2149347T3 | Spain | T3 | |
| DE69517302T2 | Germany | T2 | |
| US6228370B1 | United States of America | B1 | |
| US6835710B1 | United States of America | B1 | |
| US2005130895A1 | United States of America | A1 | |
| US7208468B2 | United States of America | B2 | |
| US2007160535A1 | United States of America | A1 | |
| CA2116179C | Canada | C | |
| US2008112525A1 | United States of America | A1 | |
| US2008224735A1 | United States of America | A1 | |
| US2008225989A1 | United States of America | A1 | |
| US2008304610A1 | United States of America | A1 | |
| US2009092213A1 | United States of America | A1 | |
| US2009147901A1 | United States of America | A1 | |
| US2009147904A1 | United States of America | A1 | |
| US2009157791A1 | United States of America | A1 | |
| US2009167374A1 | United States of America | A1 | |
| US2009172070A1 | United States of America | A1 | |
| US7560426B2 | United States of America | B2 | |
| US2009201066A1 | United States of America | A1 | |
| US2009279653A1 | United States of America | A1 | |
| US2009296867A1 | United States of America | A1 | |
| US7720189B2 | United States of America | B2 | |
| US7730650B1 | United States of America | B1 | |
| US7778371B2 | United States of America | B2 | |
| US7813466B2 | United States of America | B2 | |
| US7826563B2 | United States of America | B2 | |
| US8059778B1 | United States of America | B1 | |
| US8094754B2 | United States of America | B2 | |
| US8111785B2 | United States of America | B2 | |
| US8121242B2 | United States of America | B2 | |
| US8175207B2 | United States of America | B2 | |
| US8180011B2 | United States of America | B2 | |
| US8180012B1 | United States of America | B1 | |
| US8346840B2 | United States of America | B2 | |
| US8406365B2 | United States of America | B2 | |
| US8443023B2 | United States of America | B2 | |
| US8478805B1 | United States of America | B1 | |
| US8489664B2 | United States of America | B2 | |
| US8554815B1 | United States of America | B1 | |
| US8762436B1 | United States of America | B1 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Ceased due to non-payment of the annual feeCeasedREN | REN | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 95908853
Titles2
- German
- VEROTOXIN PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND DAMIT MEDIZINISCHE BEHANDLUNGEN
- English
- VEROTOXIN PHARMACEUTICAL COMPOSITIONS AND MEDICAL TREATMENTS THEREOF
Classification
- CPC, 3
- A61K38/164
- C07K14/245
- A61P35/00
- IPC, 4
- A61K38 00
- A61K38 16
- A61P35 00
- C07K14 245